Skip to main content


Peer Review reports

From: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial

Original Submission
21 Jul 2019 Submitted Original manuscript
8 Nov 2019 Author responded Author comments - Sanne Smith-Apeldoorn
Resubmission - Version 2
8 Nov 2019 Submitted Manuscript version 2
13 Nov 2019 Editorially accepted
29 Nov 2019 Article published 10.1186/s12888-019-2359-1

You can find further information about peer review here.

Back to article page